Efficacy of Ozoralizumab vs. Golimumab for Rheumatoid Arthritis: A Systematic Review
Introduction: Rheumatoid arthritis, a systemic autoimmune disease, affects 13% of the world population. As a well-established therapy, golimumab provides a key benchmark for assessing novel biological treatments. In contrast, ozoralizumab represents an innovative therapeutic approach. This study aim...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Faculty of Medicine, Universitas Airlangga
2025-07-01
|
| Series: | Current Internal Medicine Research and Practice Surabaya Journal |
| Subjects: | |
| Online Access: | https://e-journal.unair.ac.id/CIMRJ/article/view/66406 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|